News
Register to attend a free NIH webinar to learn about a new non-opioid small molecule for treating opioid use and substance use disorders by selectively targeting the dopamine D3 receptor. Dr. Amy Newman and her team at the National Institutes of Health’s National Institute on Drug Abuse (NIDA)
Two National Institutes of Health (NIH) inventors, Drs. Peter Basser and Carlos Zarate, Jr., have been selected as part of the 2024 National Academy of Inventors (NAI) Fellows. NAI Fellowship is the highest professional distinction awarded solely to inventors. The National Academy of Inventors is a
In the journey of commercializing a technology, a big part of the task is clearing the hurdles along the way. There can be hurdles and potential hazards from the discovery and development of a technology to the testing, manufacturing and marketing. The NIH National Center for Advancing Translational
The National Heart Lung & Blood Institute (NHLBI) and the National Cancer Institute (NCI) are seeking research co-development partners and/or licensees for a novel technology: a newly developed method of obtaining hyperpolarized imaging agents for real-time metabolic imaging using magnetic resonance